Millions of Diabetics Worldwide Struggle to Access Life-Saving Insulin
For **118 million** people living with diabetes globally, access to affordable insulin is a constant struggle. Despite being a fundamental component of diabetes treatment since 1921, when scientists **Frederick Banting** and **Charles Best** first isolated the hormone, the reality remains stark: millions can’t get their hands on this lifesaving medication.
What’s Driving the Insulin Crisis?
One major factor is the profit-driven business model of pharmaceutical companies, which price insulin at exorbitant rates. In the US, for example, a vial of insulin can cost upwards of $300. This makes it unaffordable for many low- and middle-income households. In developing countries, the situation is even bleaker, with some patients forced to pay up to $1,000 for a single vial.
Another contributor to the crisis is the lack of affordable generic versions of insulin. Although several generic manufacturers have emerged in recent years, their products are often not approved by regulatory bodies in major markets like the US and Europe. This effectively limits competition and keeps prices high.
Who’s Fighting for Affordable Insulin?
Civil society organizations, governments, and advocates are joining forces to push for reform. In 2018, the **Non-Commercial Organizations in Partnership (NCOP) Insulin Access Working Group** was launched to address the issue. NCOP members, including the **International Diabetes Federation**, are calling for greater transparency in insulin pricing and increased availability of affordable, generic alternatives.
Some governments, like **Canada**, have taken steps to address the insulin crisis by introducing policies to cap prices or impose price controls. While these measures are a step in the right direction, more needs to be done to ensure universal access to this vital medication.
What This Means
For millions of diabetics worldwide, access to affordable insulin is a matter of life and death. If governments fail to take decisive action, the consequences will be dire. By prioritizing public health over profit, governments can create a system that ensures everyone has access to this lifesaving medication.
